ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KIN Kindred Biosciences Inc

9.25
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Kindred Biosciences Inc NASDAQ:KIN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.24 9.26 0 01:00:00

Kinepolis Group: Publication of a transparency notification

21/02/2017 4:49pm

GlobeNewswire


(Article 14, first paragraph, of the law of 2 may 2007 on disclosure of major holdings)

Press release
Regulated information

21 February 2017, 17h45

Kinepolis Group NV has received a transparency notification dated 14 February 2017, indicating that Ameriprise Financial Inc. now holds, by virtue of an acquisition of shares on 9 February 2017, 3.05% of the voting rights (835.747 voting rights) of Kinepolis Group NV. As such, the threshold of 3% has been crossed.

The persons required to notify and the details of the notification, which includes the chain of controlled companies in which shares are actually held, are included in the aforementioned notification that can be consulted, together with this regulated release, on the website of Kinepolis Group via this link.

Total capital Kinepolis Group NV: 18,952,288.41 EUR
Number of securities with voting rights in Kinepolis Group NV: 27,365,197
Number of voting rights in Kinepolis Group NV: 27,365,197
In Article 8 of the Articles of Association of Kinepolis Group NV, the notification thresholds were fixed at 3%, 5% and multiples of 5%.

Contact

Kinepolis Investor Relations
+32 (0)9 241 00 22
investor-relations@kinepolis.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Kinepolis Group via Globenewswire

1 Year Kindred Biosciences Chart

1 Year Kindred Biosciences Chart

1 Month Kindred Biosciences Chart

1 Month Kindred Biosciences Chart

Your Recent History

Delayed Upgrade Clock